A website dedicated to influenza A is here.
Affymax and Takeda Pharmaceutical Company Limited are on the development of Hematide and plan jointly market the product together in the United States. The product, with the agreement will be marketed in the European Union by Takeda. Affymax is conducting Phase 3 clinical trials for Hematide for anemia in chronic renal failure and Takeda initiated Phase 1 clinical trial Phase 1 clinical trial in the U.S. To evaluate Hematide for chemotherapy-induced anemia in prostate, breast and non-small cell lung cancer to treat patients.
Adults – have CKD. Anemia develops in the early stages of CKD and worsens the patient’s progress in total kidney failure and need first to remove a dialysis machine, waste and water from their blood. In severe or prolonged cases of anemia, the lack of oxygen in the blood can cause serious and sometimes fatal damage to the heart and other organs. Benefits of anemia correction in patients with CKD include decreased morbidity, hospitalization, and mortality.1.. About anemia associated with chronic renal failure anemia in CRF affects many people with chronic kidney disease .Talk clinic is to on them and their families quality of life through the provision scientifically validated Details that will help them their condition their status got get active in the decisions can involved involvement necessary for management. Forumcl? nic is an interactive program to patients that more control over more control over their own health forum, the new technologies result. It provides a reliable, just chamber, practical advice for health and promote hands-on involvement of patients and their representative organizations.